Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Assessment of 177Lu Production through 176Yb Target Bombardment using Deuteron Particles and Back-Shifted Fermi Gas Model
Journal of Medical Physics
1 October 2025
Khorshidi A.
Open Access
Production of therapeutic radionuclides for bone-seeking radiopharmaceuticals to meet clinical exigency and academic research
Journal of Radioanalytical and Nuclear Chemistry
April 2025
Dash A.
Open Access
Evaluation of photon, proton, and alpha interaction parameters of EDTMPLu and MDPLu medications used for some bone cancer
Radiation Physics and Chemistry
March 2024
Mostafa A.M.A.
Formulation and Evaluation of an In-House Freeze-Dried EDTMP Kit for the Simple Preparation of 153Sm-Based BoneSeeking Agent EDTMP Radiopharmaceuticals
Aip Conference Proceedings
15 February 2024
Widayati P.
Open Access
Lutetium-177: Production and Radiopharmaceuticals
Nuclear Medicine Seminars
March 2023
Akit A.A.
Open Access
An optimized formulation for [99mTc]Tc radiolabeling of zoledronic acid as bone imaging agent
Iranian Journal of Nuclear Medicine
2023
Golshaiyan S.
177Lu-EDTMP radiation absorbed dose evaluation in man based on biodistribution data in Wistar rats
Nuclear Engineering and Technology
January 2023
Bagheri R.
Open Access
Biodistribution of Osteotropic 177Lu-EDTMP – a Potential Radiopharmaceutical for Radionuclide Therapy of Bone Metastases
Pharmaceutical Chemistry Journal
October 2022
Tishchenko V.K.
Antibodies and antibody constructs as radiopharmaceuticals
Nuclear Medicine and Molecular Imaging
1 January 2022
Kip A.
Photopharmacological applications for cherenkov radiation generated by clinically used radionuclides
International Journal of Molecular Sciences
2 August 2021
Krebs M.
Open Access
Progress in targeted alpha-particle-emitting radiopharmaceuticals as treatments for prostate cancer patients with bone metastases
Molecules
2 April 2021
Patel C.M.
Open Access
Comparative studies on the potential use of 177Lu-based radiopharmaceuticals for the palliative therapy of bone metastases
International Journal of Radiation Biology
2 June 2020
Zakaly H.M.H.
Targeted radionuclide therapy of painful bone metastases: Past developments, current status, recent advances and future directions
Current Medicinal Chemistry
2020
Dash A.
Bone-seeking matrix metalloproteinase-2 inhibitors prevent bone metastatic breast cancer growth
Molecular Cancer Therapeutics
March 2017
Tauro M.
All Open Access, Green
Production and clinical applications of radiopharmaceuticals and medical radioisotopes in Iran
Seminars in Nuclear Medicine
1 July 2016
Jalilian A.R.
Palliative treatment of metastatic bone pain with radiopharmaceuticals: A perspective beyond Strontium-89 and Samarium-153
Applied Radiation and Isotopes
April 01, 2016
Guerra Liberal F.D.C.
All Open Access, Green
Preparation and biological assessment of 177Lu-BPAMD as a high potential agent for bone pain palliation therapy: comparison with 177Lu-EDTMP
Journal of Radioanalytical and Nuclear Chemistry
1 February 2016
Yousefnia H.
An overview on Ga-68 radiopharmaceuticals for positron emission tomography applications
Iranian Journal of Nuclear Medicine
January 2016
Jalilian A.
Estimated human absorbed dose of 177Lu-BPAMD based on mice data: Comparison with 177Lu-EDTMP
Applied Radiation and Isotopes
October 01, 2015
Yousefnia H.
Optimized production and quality control of 68Ga-EDTMP for small clinical trials
Annals of Nuclear Medicine
25 July 2015
Mirzaei A.
Radiolabeling and evaluation of two 177Lu-labeled bis-phosphonates
Iranian Journal of Nuclear Medicine
1 June 2015
Fakhari A.
Lutetium-177 therapeutic radiopharmaceuticals: Linking chemistry, radiochemistry, and practical applications
Chemical Reviews
22 April 2015
Banerjee S.
Absorbed dose assessment of 177 Lu-zoledronate and 177 Lu-EDTMP for human based on biodistribution data in rats
Journal of Medical Physics
1 April 2015
Yousefnia H.
Open Access